Clinical Trials Browser

Phase 2 × Not yet recruiting × Neoplasms × Clear all

NCT07405736 2026-02-12

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07406789 2026-02-12

LUMInova

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasms

NCT07346677 2026-02-02

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

Phase 2 Not yet recruiting

Neoplasms, Phlebitis

NCT07378761 2026-01-30

CHILURSO

Phase 2 Not yet recruiting

Neoplasms

NCT07354919 2026-01-21

AxeCan

Phase 2 Not yet recruiting

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07356791 2026-01-21

REBIRTH-013

Phase 2 Not yet recruiting

Neoplasms

NCT07126561 2026-01-08

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Phase 2 Not yet recruiting

Neoplasm Metastasis, Neoplasms

NCT07149207 2026-01-07

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Phase 2 Not yet recruiting

Margins of Excision, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasms

NCT07279532 2025-12-12

Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System

Phase 2 Not yet recruiting

Neoplasms

NCT07274384 2025-12-10

HYPERBOLIC

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression

NCT04181463 2025-10-31

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Phase 2 Not yet recruiting

Neoplasms

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT07168226 2025-09-11

Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

Phase 2 Not yet recruiting

Cachexia, Neoplasms

NCT07077564 2025-07-22

SKB264-II-NEN

Phase 2 Not yet recruiting

Neoplasms

NCT07041788 2025-06-27

Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC

Phase 2 Not yet recruiting

Neoplasms

NCT06936748 2025-06-17

SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors

Phase 2 Not yet recruiting

Neoplasms

NCT06862323 2025-06-13

Time Restricted Eating in Haematological Malignancies

Phase 2 Not yet recruiting

LymphoidOther hematologic neoplasm

Intermittent Fasting, Inflammation, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07018063 2025-06-12

YOUNG-NEOS

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT07002502 2025-06-10

Immune Modulation With PRaG-1 Treatment

Phase 2 Not yet recruiting

Neoplasms

NCT06904300 2025-06-05

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

Phase 2 Not yet recruiting

Neoplasms

NCT06589830 2025-05-15

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT06891521 2025-03-24

Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

Phase 2 Not yet recruiting

Neoplasms

NCT06495515 2024-07-10

Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study

Phase 2 Not yet recruiting

Neoplasms

NCT06152523 2023-11-30

MONAMI

Phase 2 Not yet recruiting

Neoplasms